Modeling HIV Pre-Exposure Prophylaxis
Pre-exposure prophylaxis (PrEP) has emerged as a promising strategy for preventing the transmission of HIV. Although only one formulation is currently approved for PrEP, research into both new compounds and new delivery systems for PrEP regimens offer intriguing challenges from the perspective of ph...
Main Authors: | Thomas Straubinger, Katherine Kay, Robert Bies |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-01-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fphar.2019.01514/full |
Similar Items
-
Changing the PrEP Narrative: A Call to Action to Increase PrEP Uptake among Women
by: Alina Cernasev, et al.
Published: (2021-06-01) -
Impact of dosing strategies on plasma concentrations of tenofovir: Implications in HIV pre-exposure prophylaxis in China
by: Jingchuan Shang, et al.
Published: (2021-09-01) -
Plasma pharmacokinetics and urinary excretion of tenofovir following cessation in adults with controlled levels of adherence to tenofovir disoproxil fumarate
by: Tim R. Cressey, et al.
Published: (2020-08-01) -
HIV seroconversion during pregnancy and the need for pre-exposure prophylaxis (PrEP)
by: Zorrilla CD, et al.
Published: (2018-04-01) -
Portuguese health care providers’ knowledge, attitudes, and acceptability of HIV pre-exposure prophylaxis
by: Rui Baptista-Gonçalves, et al.
Published: (2018-11-01)